用户验证的应用
经验证应用
| 项目 | 详情 |
|---|---|
| WB | Western blot analysis of extracts from Hela(lane 1(20μg)) 、NIH/3T3(lane 2(20μg)) 、PC-12(lane 3(20μg))and Rat brain(lane 4(20μg) using Src Antibody(HY-P80338). Proteins were transferred to a PVDF membrane and blocked with 5%BSA in TBST for 1.5 hour at room temperature. The primary antibody ( 1/2000) and Loading control antibody (GAPDH, 1/1000) was used in 5% BSA in TBST at 4℃ overnight. Goat Anti-Rabbit IgG-HRP Secondary Antibody (1/10,000) was used for 1 hour at room temperature. Western blot analysis of extracts from A549(lane 2(20ug), NIH/3T3(lane 3(20ug) and C6(lane 4(20ug) using Src Antibody ( HY-P80338 ) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P83730, 1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature. |
| IHC-P | Immunohistochemical analysis of paraffin-embedded mouse kidney tissue using Src Antibody. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) for 8 minutes. The tissues were blocked in QuickBlock for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody at 1/100 dilution in 4℃ overnight. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. Immunohistochemical analysis of paraffin-embedded human prostate cancer tissue using Src antibody. The section was pre-treated using heat mediated antigen retrieval with Tris/EDTA buffer (pH 9.0) for 20 minutes. The tissues were probed with the primary antibody (HY-P80338, 1/100) overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with neutral balsam. Immunohistochemical analysis of paraffin-embedded human gastric cancer tissue using Src antibody. The section was pre-treated using heat mediated antigen retrieval with Tris/EDTA buffer (pH 9.0) for 20 minutes. The tissues were probed with the primary antibody (HY-P80338, 1/100) overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with neutral balsam. Immunohistochemical analysis of paraffin-embedded human pancreatic cancer tissue using Src antibody. The section was pre-treated using heat mediated antigen retrieval with Tris/EDTA buffer (pH 9.0) for 20 minutes. The tissues were probed with the primary antibody (HY-P80338, 1/100) overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with neutral balsam. Immunohistochemical analysis of paraffin-embedded human bladder cancer tissue using Src antibody. The section was pre-treated using heat mediated antigen retrieval with Tris/EDTA buffer (pH 9.0) for 20 minutes. The tissues were probed with the primary antibody (HY-P80338, 1/100) overnight at 4℃. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with neutral balsam. |
| ICC | Immunocytochemistry analysis of U2OS cells labeling Src with Src Antibody ( HY-P80338 ) at 1/100 dilution. Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with quick block buffer for 10 minutes at room temperature. Cells were then incubated with Src Antibody ( HY-P80338 ) at 1/100 dilution in quick block buffer overnight at 4 ℃. AF488-conjugated Goat Anti-Rabbit IgG H&L(HY-P8002, Green) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. The Nuclear counterstain was DAPI (Blue). Immunocytochemistry analysis of U2OS cells labeling Src with Src Antibody ( HY-P80338 ) at 1/300 dilution. Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with quick block buffer for 10 minutes at room temperature. Cells were then incubated with Src Antibody ( HY-P80338 ) at 1/300 dilution in quick block buffer overnight at 4 ℃. AF488-conjugated Goat Anti-Rabbit IgG H&L(HY-P8002, Green) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. The Nuclear counterstain was DAPI (Blue). |
推荐稀释比例
- WB1:1000-1:5000
- ICC/IF1:100-1:500
- IHC-P1:50-1:200
- FC1:50-1:100
详细信息
背景信息
功能: Src 家族激酶 (SFK) 是一个非受体酪氨酸激酶家族,包括 9 个成员:Src、Yes、Fyn 和 Fgr,形成 SrcA 亚家族;Lck、Hck、Blk 和 Lyn 形成 SrcB 亚家族;Frk 形成其自己的亚家族。在免疫细胞中,Src 家族激酶 (SFK) 被认为是大量细胞内信号通路的关键调节剂。Src 家族激酶 (SFK) 在许多信号转导级联中占据近端位置,包括来自 T 细胞和 B 细胞抗原受体、Fc 受体、生长因子受体、细胞因子受体和整合素的信号转导级联。除了这些正向调节作用之外,Src 家族激酶 (SFK) 还可以通过磷酸化抑制受体上的免疫受体酪氨酸抑制基序 (ITIM),充当细胞信号转导的负向调节剂,从而募集和激活抑制分子,例如含有 5′ 肌醇磷酸酶 (SHIP-1) 的磷酸酶 SHP-1 和 SH2。 亚细胞定位: 细胞膜;脂锚;线粒体内膜;细胞核;细胞质,细胞骨架;细胞质,核周区;细胞连接,黏着斑;细胞连接 表达水平: 组织特异性:广泛表达。在皮肤中表达 (蛋白水平) (PubMed:22294297) 。血小板、神经元和破骨细胞中的表达水平比大多数其他组织高 5 倍至 200 倍;在脾脏和肝脏中表达;在脑中表达;在脑中表达 亚基: 该蛋白是 PTPRA、BCAR1、BCAR3 (通过 SH2 结构域) 和 SRC 组成的复合物的一部分;该复合物的形成依赖于整合素介导的 PTPRA 酪氨酸磷酸化 (PubMed:22801373)。它通过 SH3 结构域与 DDEF1/ASAP1 相互作用 (基于序列相似性)。它与 CCPG1 相互作用 (基于序列相似性)。它存在于包含 FGFR4、NCAM1、CDH2、PLCG1、FRS2、SRC、SHC1、GAP43 和 CTTN 的复合物中 (基于序列相似性)。它与 ERBB2、STAT1 和 PNN 相互作用 (基于序列相似性)。它与 DDR1、DDR2 和 DAB2 相互作用 (基于序列相似性)。与 CDCP1、TGFB1I1 和 TOM1L2 相互作用 (PubMed:15851033、PubMed:16479011、PubMed:17202804)。与 MUC1 的胞质结构域相互作用,使其磷酸化并增强 MUC1 与 β-catenin 的结合 (PubMed:11152665)。通过 SH3 结构域与 RALGPS1 相互作用 (PubMed:10747847)。与 CAV2 (酪氨酸磷酸化形式) 相互作用 (PubMed:12091389、PubMed:15504032)。通过 SH3 结构域和蛋白激酶结构域与 ARRB1 相互作用;该相互作用与 SRC C 端磷酸化状态无关 (基于相似性)。与 ARRB1 和 ARRB2 相互作用 (PubMed:10753943,PubMed:9924018)。与 SRCIN1 相互作用 (PubMed:17525734)。与 NDFIP2 相互作用,与 NDFIP1 的相互作用较弱 (PubMed:20534535)。与 PIK3CA 和/或 PIK3C2B、PTK2/FAK1 以及 ESR1 (精氨酸二甲基化) 相互作用 (PubMed:18657504,PubMed:21411625)。与 FASLG 相互作用 (PubMed:19807924)。通过 SH2 结构域与 PTK2B/PYK2 的“Tyr-402”磷酸化形式相互作用 (PubMed:14585963)。通过 SH2 结构域与 FLT3 (酪氨酸磷酸化) 相互作用 (基于相似性)。与 PDGFRA (酪氨酸磷酸化) 相互作用 (基于相似性)。与 CSF1R 相互作用 (基于相似性)。通过 SH2 和 SH3 结构域与 TNK2 相互作用 (PubMed:21309750)。通过蛋白激酶结构域与 RUNX3 的酪氨酸磷酸化形式 (通过 runt 结构域) 相互作用 (PubMed:20100835)。通过 RING 型锌指结构域与 TRAF3 相互作用 (PubMed:19419966)。与 RIGI、MAVS 和 TBK1 相互作用 (PubMed:19419966)。通过 SH2 结构域与 RACK1 相互作用; RACK1 酪氨酸磷酸化增强了该相互作用,并抑制 SRC 活性 (PubMed:11279199, PubMed:9584165)。与 EPHB1 相互作用;激活 MAPK/ERK 级联反应以调节细胞迁移 (PubMed:12925710)。与 FCAMR 相互作用 (PubMed:8759729)。通过 SH2 结构域与 PDPK1 的“Tyr-9”磷酸化形式相互作用 (PubMed:18024423)。与 AMOTL2 相互作用;该相互作用调节磷酸化 SRC 向外周细胞-基质粘附位点的转位 (PubMed:17293535)。与 TRAP1 相互作用 (PubMed:23564345)。与 CBLC 相互作用;当 SRC 在 Tyr-419 位点磷酸化时,其相互作用增强 (PubMed:14661060, PubMed:22888118)。与 ARHGEF5 相互作用 (基于相似性)。通过胞质结构域与 CEACAM1 (通过 SH2 结构域) 相互作用;这种相互作用受跨同型细胞黏附调控 (PubMed:7478590)。与 MPP2 相互作用 (PubMed:19665017)。与 PRR7 相互作用 (PubMed:21460222)。通过激酶结构域 (以及较弱的 SH2 结构域) 直接与 PDLIM4 相互作用;这种相互作用导致 PTPN13 介导的 PDLIM4 去磷酸化,进而导致其失活 (PubMed:19307596)。与 P85 (PIK3R1 或 PIK3R2) 相互作用 (PubMed:28903391)。与 HNRNPA2B1 相互作用 (PubMed:31320558)。与 IL6ST/gp130 相互作用 (PubMed:25731159)。在 17β-雌二醇存在下,通过 SH3 结构域与 PELP1 相互作用。与 AMBRA1 相互作用 (基于相似性)。